New Zealand markets close in 45 minutes

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.40+1.98 (+5.15%)
At close: 04:00PM EDT
40.58 +0.18 (+0.45%)
After hours: 06:48PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
351,185
551,801
640,192
565,779
-
Other short-term investments
-
0
60,358
311,869
0
Total cash
351,185
551,801
700,550
877,648
-
Net receivables
206,442
7,727
10,103
0
-
Inventory
146,362
85,714
16,286
0
-
Other current assets
4,354
6,505
70,677
26,878
-
Total current assets
766,331
719,523
824,047
917,192
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
21,090
24,895
26,078
24,522
-
Net property, plant and equipment
21,090
24,895
26,078
24,522
-
Other long-term assets
1,309
15,799
31,640
18,855
-
Total non-current assets
22,399
40,694
57,718
43,377
-
Total assets
788,730
760,217
881,765
960,569
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
37,516
37,342
16,909
8,477
-
Accrued liabilities
127,806
95,139
103,239
111,935
-
Other current liabilities
75,830
29,504
7,584
4,230
-
Total current liabilities
247,593
167,610
131,847
128,327
-
Non-current liabilities
Long-term debt
93,033
92,736
189,024
358,830
-
Other long-term liabilities
242,129
315,647
345,151
-
-
Total non-current liabilities
346,616
422,735
551,256
627,685
-
Total liabilities
594,209
590,345
683,103
756,012
-
Stockholders' equity
Common stock
12
11
10
8
-
Retained earnings
-2,837,488
-2,308,860
-1,656,688
-926,347
-
Accumulated other comprehensive income
-3,542
-875
-2,090
-117
-
Total stockholders' equity
194,521
169,872
198,662
204,557
-
Total liabilities and stockholders' equity
788,730
760,217
881,765
960,569
-